BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 14739095)

  • 21. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.
    Srivastava A; Chaturvedi S; Gupta RK; Malik R; Mathias A; Jagannathan NR; Jain S; Pandey CM; Yachha SK; Rathore RKS
    J Hepatol; 2017 Mar; 66(3):528-536. PubMed ID: 27815224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Umbelliferone prevents oxidative stress, inflammation and hematological alterations, and modulates glutamate-nitric oxide-cGMP signaling in hyperammonemic rats.
    Germoush MO; Othman SI; Al-Qaraawi MA; Al-Harbi HM; Hussein OE; Al-Basher G; Alotaibi MF; Elgebaly HA; Sandhu MA; Allam AA; Mahmoud AM
    Biomed Pharmacother; 2018 Jun; 102():392-402. PubMed ID: 29573618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
    Ishikawa T; Endo S; Imai M; Azumi M; Nozawa Y; Sano T; Iwanaga A; Honma T; Yoshida T
    Intern Med; 2020; 59(20):2465-2469. PubMed ID: 33055469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
    Tapper EB; Jiang ZG; Patwardhan VR
    Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic encephalopathy, hyperammonemia, and ammonia toxicity. Papers presented at the International Symposium on Cirrhosis, Hyperammonemia and hepatic encephalopathy. Valencia, Spain, January 24-27, 1994.
    Adv Exp Med Biol; 1994; 368():1-205. PubMed ID: 7740999
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
    Rodrigo R; Felipo V
    Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
    Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
    J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
    J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.
    Mani AR; Montagnese S; Jackson CD; Jenkins CW; Head IM; Stephens RC; Moore KP; Morgan MY
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G330-8. PubMed ID: 19023029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy.
    Douglass A; Al Mardini H; Record C
    J Hepatol; 2001 May; 34(5):658-64. PubMed ID: 11434611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
    Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
    Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Positron emission tomography (PET) before and after treatment of hyperammonemia in a patient with decompensated liver cirrhosis].
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Murai K; Sadoshima S; Fujishima M; Ichiya Y
    Fukuoka Igaku Zasshi; 1991 Oct; 82(10):521-7. PubMed ID: 1748367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt.
    Jalan R; Gooday R; O'Carroll RE; Redhead DN; Elton RA; Hayes PC
    J Hepatol; 1995 Dec; 23(6):697-705. PubMed ID: 8750169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY IN ROMANIAN CIRRHOTIC PATIENTS--PARTIAL RESULTS.
    Badea MA; Prelipcean CC; Mihai C; Popa I; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):368-73. PubMed ID: 26204638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.